Portal:COVID-19/CoveredPWs
From WikiPathways
(Difference between revisions)
| Line 1: | Line 1: | ||
{| class="wikitable sortable" style="float:left; margin-left: 10px;" | {| class="wikitable sortable" style="float:left; margin-left: 10px;" | ||
| - | ! Title || Links WP || Category || Status | + | ! Title || Comment || Links WP || Category || Status |
|- | |- | ||
| - | | SARS-CoV-2 and COVID-19 Pathway || [https://www.wikipathways.org/index.php/Pathway:WP4846 WP4846] || SARS-CoV-2 Pathways || style="font-style: italic; color: blue;" | Approved | + | | SARS-CoV-2 and COVID-19 Pathway|| Collaborative project for curation of biological processes <br/> involved in the COVID-19 disease after SARS-Cov-2 infection. || [https://www.wikipathways.org/index.php/Pathway:WP4846 WP4846] || SARS-CoV-2 Pathways || style="font-style: italic; color: blue;" | Approved |
|- | |- | ||
| - | | Hijack of Ubiquitination by SARS-CoV-2 || [https://www.wikipathways.org/index.php/Pathway:WP4860 WP4860] || SARS-CoV-2 Pathways || style="font-style: italic; color: blue;" | Approved | + | | Hijack of Ubiquitination by SARS-CoV-2 || || [https://www.wikipathways.org/index.php/Pathway:WP4860 WP4860] || SARS-CoV-2 Pathways || style="font-style: italic; color: blue;" | Approved |
|- | |- | ||
| - | | Type I Interferon Induction and Signaling During SARS-CoV-2 Infection || [https://www.wikipathways.org/index.php/Pathway:WP4868 WP4868] || SARS-CoV-2 Pathways || style="font-style: italic; color: orange;" | In Progress | + | | Type I Interferon Induction and Signaling During SARS-CoV-2 Infection || || [https://www.wikipathways.org/index.php/Pathway:WP4868 WP4868] || SARS-CoV-2 Pathways || style="font-style: italic; color: orange;" | In Progress |
|- | |- | ||
| - | | COVID-19, thrombosis and anticoagulation || [https://www.wikipathways.org/index.php/Pathway:WP4927 WP4927] || SARS-CoV-2 Pathways || style="font-style: italic; color: orange;" | In Progress | + | | COVID-19, thrombosis and anticoagulation || || [https://www.wikipathways.org/index.php/Pathway:WP4927 WP4927] || SARS-CoV-2 Pathways || style="font-style: italic; color: orange;" | In Progress |
|- | |- | ||
| - | | Activation of NLRP3 Inflammasome by SARS-CoV-2 || [https://www.wikipathways.org/index.php/Pathway:WP4876 WP4876] || SARS-CoV-2 Pathways || style="font-style: italic; color: orange;" | In Progress | + | | Activation of NLRP3 Inflammasome by SARS-CoV-2 || || [https://www.wikipathways.org/index.php/Pathway:WP4876 WP4876] || SARS-CoV-2 Pathways || style="font-style: italic; color: orange;" | In Progress |
|- | |- | ||
| - | | SARS-CoV-2 and Angiotensin-converting enzyme 2 (ACE2) receptor: <br/> Molecular mechanisms and potential therapeutic target || [https://www.wikipathways.org/index.php/Pathway:WP4883 WP4883] || SARS-CoV-2 Pathways || style="font-style: italic; color: orange;" | In Progress | + | | SARS-CoV-2 and Angiotensin-converting enzyme 2 (ACE2) receptor: <br/> Molecular mechanisms and potential therapeutic target || || [https://www.wikipathways.org/index.php/Pathway:WP4883 WP4883] || SARS-CoV-2 Pathways || style="font-style: italic; color: orange;" | In Progress |
|- | |- | ||
| - | | COVID-19 AOP || [https://www.wikipathways.org/index.php/Pathway:WP4891 WP4891] || SARS-CoV-2 Pathways || style="font-style: italic; color: orange;" | In Progress | + | | COVID-19 AOP || || [https://www.wikipathways.org/index.php/Pathway:WP4891 WP4891] || SARS-CoV-2 Pathways || style="font-style: italic; color: orange;" | In Progress |
|- | |- | ||
| - | | nsp9/nsp10-mediated SARS-CoV-2 pathogenesis || [https://www.wikipathways.org/index.php/Pathway:WP4884 WP4884] || SARS-CoV-2 Pathways || style="font-style: italic; color: orange;" | In Progress | + | | nsp9/nsp10-mediated SARS-CoV-2 pathogenesis || || [https://www.wikipathways.org/index.php/Pathway:WP4884 WP4884] || SARS-CoV-2 Pathways || style="font-style: italic; color: orange;" | In Progress |
|- | |- | ||
| - | | LDLRAD4 pathway in COVID-19 || [https://www.wikipathways.org/index.php/Pathway:WP4904 WP4904] || SARS-CoV-2 Pathways || style="font-style: italic; color: orange;" | In Progress | + | | LDLRAD4 pathway in COVID-19 || || [https://www.wikipathways.org/index.php/Pathway:WP4904 WP4904] || SARS-CoV-2 Pathways || style="font-style: italic; color: orange;" | In Progress |
|- | |- | ||
| - | | Overview of perturbations to host-cell autophagy,<br/> induced by distinct proteins of SARS-CoV-2 || [https://www.wikipathways.org/index.php/Pathway:WP4936 WP4936] || SARS-CoV-2 Pathways || style="font-style: italic; color: orange;" | In Progress | + | | Overview of perturbations to host-cell autophagy,<br/> induced by distinct proteins of SARS-CoV-2 || || [https://www.wikipathways.org/index.php/Pathway:WP4936 WP4936] || SARS-CoV-2 Pathways || style="font-style: italic; color: orange;" | In Progress |
|- | |- | ||
| - | + | | Coronavirus lipid metabolism || || [https://www.wikipathways.org/index.php/Pathway:WP4853 WP4853] || Other coronaviruses || style="font-style: italic; color: orange;" | In Progress | |
| - | | Coronavirus lipid metabolism || [https://www.wikipathways.org/index.php/Pathway:WP4853 WP4853] || Other coronaviruses || style="font-style: italic; color: orange;" | In Progress | + | |
|- | |- | ||
| - | | Host-pathogen interaction of human corona viruses - autophagy || [https://www.wikipathways.org/index.php/Pathway:WP4863 WP4863] || Other coronaviruses || style="font-style: italic; color: orange;" | In Progress | + | | Host-pathogen interaction of human corona viruses - autophagy || || [https://www.wikipathways.org/index.php/Pathway:WP4863 WP4863] || Other coronaviruses || style="font-style: italic; color: orange;" | In Progress |
|- | |- | ||
| - | | Host-pathogen interaction of human corona viruses - apoptosis || [https://www.wikipathways.org/index.php/Pathway:WP4864 WP4864] || Other coronaviruses || style="font-style: italic; color: orange;" | In Progress | + | | Host-pathogen interaction of human corona viruses - apoptosis || || [https://www.wikipathways.org/index.php/Pathway:WP4864 WP4864] || Other coronaviruses || style="font-style: italic; color: orange;" | In Progress |
|- | |- | ||
| - | | SARS coronavirus and innate immunity || [https://www.wikipathways.org/index.php/Pathway:WP4912 WP4912] || Other coronaviruses || style="font-style: italic; color: orange;" | In Progress | + | | SARS coronavirus and innate immunity || || [https://www.wikipathways.org/index.php/Pathway:WP4912 WP4912] || Other coronaviruses || style="font-style: italic; color: orange;" | In Progress |
|- | |- | ||
| - | | ER stress response in Coronavirus infection || [https://www.wikipathways.org/index.php/Pathway:WP4861 WP4861] || Other coronaviruses || style="font-style: italic; color: orange;" | In Progress | + | | ER stress response in Coronavirus infection || || [https://www.wikipathways.org/index.php/Pathway:WP4861 WP4861] || Other coronaviruses || style="font-style: italic; color: orange;" | In Progress |
|- | |- | ||
| - | | Downregulation of ACE2 expression by SARS-CoV <br/>infection and SARS-CoV Spike protein || [https://www.wikipathways.org/index.php/Pathway:WP4799 WP4799] || Other coronaviruses || style="font-style: italic; color: orange;" | In Progress | + | | Downregulation of ACE2 expression by SARS-CoV <br/>infection and SARS-CoV Spike protein || || [https://www.wikipathways.org/index.php/Pathway:WP4799 WP4799] || Other coronaviruses || style="font-style: italic; color: orange;" | In Progress |
|- | |- | ||
| - | | Host-pathogen interaction of human <br/> corona viruses - MAPK signaling|| [https://www.wikipathways.org/index.php/Pathway:WP4877 WP4877] || Other coronaviruses || style="font-style: italic; color: orange;" | In Progress | + | | Host-pathogen interaction of human <br/> corona viruses - MAPK signaling || || [https://www.wikipathways.org/index.php/Pathway:WP4877 WP4877] || Other coronaviruses || style="font-style: italic; color: orange;" | In Progress |
|- | |- | ||
| - | | Host-pathogen interaction of human <br/> corona viruses - Interferon induction || [https://www.wikipathways.org/index.php/Pathway:WP4880 WP4880] || Other coronaviruses || style="font-style: italic; color: orange;" | In Progress | + | | Host-pathogen interaction of human <br/> corona viruses - Interferon induction || || [https://www.wikipathways.org/index.php/Pathway:WP4880 WP4880] || Other coronaviruses || style="font-style: italic; color: orange;" | In Progress |
|- | |- | ||
| - | | ACE Inhibitor Pathway|| [https://www.wikipathways.org/index.php/Pathway:WP554 WP554] || ACE2 || style="font-style: italic; color: orange;" | In Progress | + | | ACE Inhibitor Pathway |||| [https://www.wikipathways.org/index.php/Pathway:WP554 WP554] || ACE2 || style="font-style: italic; color: orange;" | In Progress |
|- | |- | ||
| - | | Metabolism of Angiotensinogen to Angiotensins (Reactome) || [https://www.wikipathways.org/index.php/Pathway:WP2729 WP2729] || ACE2 || style="font-style: italic; color: orange;" | In Progress | + | | Metabolism of Angiotensinogen to Angiotensins (Reactome) || || [https://www.wikipathways.org/index.php/Pathway:WP2729 WP2729] || ACE2 || style="font-style: italic; color: orange;" | In Progress |
|- | |- | ||
|} | |} | ||
Revision as of 19:33, 9 September 2020
| Title | Comment | Links WP | Category | Status |
|---|---|---|---|---|
| SARS-CoV-2 and COVID-19 Pathway | Collaborative project for curation of biological processes involved in the COVID-19 disease after SARS-Cov-2 infection. | WP4846 | SARS-CoV-2 Pathways | Approved |
| Hijack of Ubiquitination by SARS-CoV-2 | WP4860 | SARS-CoV-2 Pathways | Approved | |
| Type I Interferon Induction and Signaling During SARS-CoV-2 Infection | WP4868 | SARS-CoV-2 Pathways | In Progress | |
| COVID-19, thrombosis and anticoagulation | WP4927 | SARS-CoV-2 Pathways | In Progress | |
| Activation of NLRP3 Inflammasome by SARS-CoV-2 | WP4876 | SARS-CoV-2 Pathways | In Progress | |
| SARS-CoV-2 and Angiotensin-converting enzyme 2 (ACE2) receptor: Molecular mechanisms and potential therapeutic target | WP4883 | SARS-CoV-2 Pathways | In Progress | |
| COVID-19 AOP | WP4891 | SARS-CoV-2 Pathways | In Progress | |
| nsp9/nsp10-mediated SARS-CoV-2 pathogenesis | WP4884 | SARS-CoV-2 Pathways | In Progress | |
| LDLRAD4 pathway in COVID-19 | WP4904 | SARS-CoV-2 Pathways | In Progress | |
| Overview of perturbations to host-cell autophagy, induced by distinct proteins of SARS-CoV-2 | WP4936 | SARS-CoV-2 Pathways | In Progress | |
| Coronavirus lipid metabolism | WP4853 | Other coronaviruses | In Progress | |
| Host-pathogen interaction of human corona viruses - autophagy | WP4863 | Other coronaviruses | In Progress | |
| Host-pathogen interaction of human corona viruses - apoptosis | WP4864 | Other coronaviruses | In Progress | |
| SARS coronavirus and innate immunity | WP4912 | Other coronaviruses | In Progress | |
| ER stress response in Coronavirus infection | WP4861 | Other coronaviruses | In Progress | |
| Downregulation of ACE2 expression by SARS-CoV infection and SARS-CoV Spike protein | WP4799 | Other coronaviruses | In Progress | |
| Host-pathogen interaction of human corona viruses - MAPK signaling | WP4877 | Other coronaviruses | In Progress | |
| Host-pathogen interaction of human corona viruses - Interferon induction | WP4880 | Other coronaviruses | In Progress | |
| ACE Inhibitor Pathway | WP554 | ACE2 | In Progress | |
| Metabolism of Angiotensinogen to Angiotensins (Reactome) | WP2729 | ACE2 | In Progress |
Pathway categories
The pathways on this portal are grouped in the following categories: SARS-CoV-2 Pathways, Other coronaviruses (e.g. MERS, SARS-CoV) and virus-host specific interactions (e.g. ACE2).
Contact us
Send questions about WikiPathways to the wikipathways-discuss mailing list.
How to add a pathway to the portal
The list of Featured Pathways is not static and can be updated at any time. If you know of a pathway that should be added, please contact the administrator.
- See our Help section for New Contributor QuickStart, Editor's Palette Guide and Guidelines for Contributors.
